The world of cells is surprisingly noisy. Each cell carries unique genetic information, but when we try to measure cellular activity, signals can be lost or blurred, and differences between ...

Tempus AITEM stock surged to a record-high Monday after the Food and Drug Administration cleared its new device to help drugmakers analyze RNA. RNA analysis is helpful in determining the mechanisms of ...

They’re harnessing it to help directors prepare, debate, and decide. by Stanislav Shekshnia and Valery Yakubovich In 2014 Hong Kong–based Deep Knowledge Ventures formally appointed an algorithm to its ...

Tempus AI Inc (NASDAQ:TEM) shares are trading higher Monday morning after the company announced it has received U.S. Food and Drug Administration 510(k) clearance for its RNA-based Tempus xR IVD ...

Stanford Medicine researchers have developed an artificial intelligence tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing "copilot" ...